HAS Healthcare Advanced Synthesis’s showcase at CPhI Worldwide 2022, in Frankfurt Booth 80C70 in Hall 8.0.
Biasca, Switzerland, November 1, 2022 – HAS Healthcare Advanced Synthesis SA, a full-service contract development and manufacturing organization (CDMO) delivering high-quality, exclusive, personalized solutions to its healthcare clients, today announces its participation in CPhI Worldwide 2022, hosted in Messe Frankfurt, Germany, between November 1 – 3, 2022.
HAS Healthcare Advanced Synthesis is thrilled to be present as exhibitor with its Booth 80C70 in Hall 8.0., at the biggest annual international pharma industry event which brings together key players, drives important networking, grows the community and unlocks new business opportunities.
HAS Healthcare Advanced Synthesis’s booth will showcase its contracting manufacturing operations located in Switzerland, which serves its clients in the pharmaceutical industry as an innovative and technology-advanced plant.
HAS Healthcare Advanced Synthesis offers exclusive, personalized services to its clients, including the development and manufacturing of Active Pharmaceutical Ingredients (APIs), cGMP Advanced Intermediates, High Potency APIs (HPAPIs) and anticancer compounds, and supports its clients with their analytical and regulatory requirements. It has always endeavored to deliver a cutting-edge service to clients on their key projects by investing in innovative technology whilst reducing the environmental impact of its activities.
Waldo Mossi, CEO of HAS Healthcare Advanced Synthesis, comments: “We are delighted to be at this major event, at the heart of pharma, where the pharmaceutical world gathers to exhibit, meet and discuss business opportunities. Please join us, our Team is ready to welcome you at our Booth 80C70 in Hall 8.0 and explain how we can embrace your challenges and tailor your needs at our facilities located in Switzerland”.
If you cannot make it to Frankfurt, connect to our website and learn more on how we offer the best CDMO standards as a full-service partner to our healthcare clients: www.hashealthcare.com.
ENDS
About HAS Healthcare Advanced Synthesis
HAS Healthcare Advanced Synthesis is a full-service CDMO committed to providing a reliable, first-class and tailor-made offering. The company develops and manufactures Active Pharmaceutical Ingredients (APIs), cGMP Advanced Intermediates, High Potency APIs (HPAPIs) and anticancer compounds for its clients from clinical to commercial supply, on an exclusive basis.
The production plant is located in Biasca, Switzerland and was established in 1984. The site is routinely inspected by the FDA, SwissMedic, and other global regulatory agencies. Production scale ranges from grams to tens of kilograms for HPAPIs and Anticancer compounds from kilograms up to tens of tons (APIs) in plants fully dedicated to cGMP manufacturing.
Please visit our website for more information: https://www.hashealthcare.com
For more information:
HAS Healthcare Advanced Synthesis Media Contact
Biasca, Switzerland
Giulia Rigonalli
Tel: +41 (0) 91 873 94 00
Email: [email protected]